MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 5.86
-0.01 (-0.17%)
Apr 29, 2026, 2:24 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €110.61 million as of April 29, 2026. Its market cap has increased by 11.28% in one year.
Market Cap
110.61M
Enterprise Value
103.19M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.86
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 110.61M, a decrease of -16.66%. That is a compound annual growth rate of -4.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 110.61M | 42.79% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 105.09M |
| Adocia | 90.87M |
| ABIONYX Pharma | 127.00M |
| Valerio Therapeutics Société anonyme | 76.26M |
| OSE Immunotherapeutics | 67.80M |
| Sensorion | 194.82M |
| Fermentalg | 51.49M |
| Transgene | 207.33M |